Latest Articles
Lifesaving breast cancer and endometriosis drug to be pulled from shelves - Australian Broadcasting Corporation
Lifesaving breast cancer and endometriosis drug to be pulled from shelves Australian Broadcasting Corporation
Published: June 3, 2026, 6:49 p.m.
Life-saving breast cancer and endometriosis drug to be pulled from shelves - Australian Broadcasting Corporation
Life-saving breast cancer and endometriosis drug to be pulled from shelves Australian Broadcasting Corporation
Published: June 3, 2026, 6:49 p.m.
The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study - apd.cat
The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study apd.cat
Published: June 3, 2026, 3:47 p.m.
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post
Published: June 3, 2026, 2:49 p.m.
Robin Quivers Announces Remission Following Endometrial Cancer Battle - sekbernews.id
Robin Quivers Announces Remission Following Endometrial Cancer Battle sekbernews.id
Published: June 3, 2026, 2:32 p.m.
Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle - HarianBasis.co
Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle HarianBasis.co
Published: June 3, 2026, 2:31 p.m.
Optical coherence tomography enables optical biopsy of endometrial tissue for early cancer detection - Nature
Optical coherence tomography enables optical biopsy of endometrial tissue for early cancer detection Nature
Published: June 3, 2026, 2:27 p.m.
Ibuprofen and endometrial cancer: An observational study finds a positive association. - unicaradio.it
Ibuprofen and endometrial cancer: An observational study finds a positive association. unicaradio.it
Published: June 3, 2026, 8:48 a.m.
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer - Oncodaily
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer Oncodaily
Published: June 3, 2026, 3:15 a.m.
Cancer researchers present advances and emerging treatments - ABS-CBN
Cancer researchers present advances and emerging treatments ABS-CBN
Published: June 3, 2026, 2:53 a.m.
Link copied to clipboard!